PSMA PET/CT Scan Reduces Need for Prostate Cancer Biopsies by 50% - Takeaway - MDSpire
Clinical Guidelines

PSMA PET/CT Scan Reduces Need for Prostate Cancer Biopsies by 50%

A PSMA-11 PET/CT scan with gallium Ga-68 led to the identification of more aggressive prostate cancer cells in men with equivocal or nonsuspicious findings on multiparametric MRI than a standard biops...

Share

  • 1

    PSMA-11 PET/CT scans can reduce unnecessary biopsies for prostate cancer.

  • 2

    49% of patients avoided biopsies in the PSMA PET/CT arm.

  • 3

    The trial involved 660 men across seven Australian hospitals.

  • 4

    Results indicate that insignificant cancer diagnoses decreased significantly.

  • 5

    The study supports PSMA PET/CT's integration into diagnostic workflows.

  • 6

    Gleason scores help determine the significance of prostate cancer.

  • 7

    The findings were presented at the EAU 2026 Congress.

Original Source(s)

PSMA PET/CT Scan Reduces Need for Prostate Cancer Biopsies by 50%

  • by The ASCO Post Staff

  • April 14, 2026

Related Content

Prompting Strategies May Improve Symptom Monitoring in Childhood Cancer Survivors

Prompting strategies on two large language models improved how the artificial intelligence (AI) interpreted pain and fatigue reported by survivors of childhood cancers for better symptom monitoring an...

FDA Fast-Tracks Off-the-Shelf CAR-T for Aggressive T-Cell Cancers

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.

  • April 14, 2026

  • 2 min
Fluorine Tracking Offers Safer Alternative to Radioactive Drug Metabolism Studies

ICP-MS method enables early, quantitative metabolite analysis without radiolabels

  • April 14, 2026

  • 2 min